Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126490) titled 'Demonstration Project for the Application of Human KRAS/BRAF/PIK3CA Gene Mutation Detection Kit in Screening Cetuximab Indications for Colorectal Cancer' on June 10.
Study Type: Observational study
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Condition:
colorectal cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-01
Target Sample Size: Observation group:400;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=323098
Disclaimer...